Agios Pharmaceuticals Inc (NASDAQ:AGIO) price on current trading day, rose 4.53% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $61.64.
A look at the stock’s price movement, the close in the last trading session was $58.97, moving within a range at $59.09 and $62.45. The beta value (5-Year monthly) was 0.751 while the PE ratio in trailing twelve months stood at 5.42. Turning to its 52-week performance, $62.58 and $20.96 were the 52-week high and 52-week low respectively. Overall, AGIO moved 19.48% over the past month.
Agios Pharmaceuticals Inc’s market cap currently stands at around $3.67 billion, with investors looking forward to this quarter’s earnings report slated for in January.
Analysts have a consensus estimate of 9.29M for the company’s revenue for the quarter, with a low and high estimate of 8M and 10.94M respectively. The average forecast suggests up to a 30.75% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 35.11M, representing a 30.89% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that AGIO is a 100% Buy. On the other hand, the stock is on average a 100% Buy as suggested by medium term indicators while long term indicators are putting the stock in 100% Buy category.
5 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 1 analyst(s) rate the stock as a Hold, 4 recommend AGIO as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
AGIO’s current price about 7.02% and 24.10% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 71.30, while 7-day volatility ratio is 4.44% and 4.70% in the 30-day chart. Further, Agios Pharmaceuticals Inc (AGIO) has a beta value of 0.78, and an average true range (ATR) of 2.45. Analysts have given the company’s stock an average 52-week price target of $53.5, forecast between a low of $51 and high of $56. Looking at the price targets, the low is 17.26% off current price level while to achieve the yearly target high, price needs to move 9.15%. Nonetheless, investors will most likely welcome a 13.21% jump to $53.5 which is the analysts’ median price.
If we refocus on Agios Pharmaceuticals Inc (NASDAQ:AGIO), historical trading data shows that trading volumes averaged 0.49 over the past 10 days and 585.58K over the past 3 months. The company’s latest data on shares outstanding shows there are 57.02 million shares.
The 3.32% of Agios Pharmaceuticals Inc’s shares are in the hands of company insiders while institutional holders own 104.92% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 4.55 million on 2024-11-15, giving us a short ratio of 6.65. The data shows that as of 2024-11-15 short interest in Agios Pharmaceuticals Inc (AGIO) stood at 809.0 of shares outstanding, with shares short rising to 4.11 million registered in 2024-10-15. Current price change has pushed the stock 176.78% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the AGIO stock continues to rise going into the next quarter.
